Circadian Variation in Anti-Factor Xa (Anti-FXa) ActivitySleep
What this study is
The purpose of this study is to determine whether a circadian rhythm exists in anti-FXa levels and AT3 activity in hospitalized trauma patients receiving low-molecular-weight heparin (LMWH) chemoprophylaxis
Study details
- Sponsor
- The University of Texas Health Science Center, Houston
- Conditions
- Circadian Variation in Anti-Factor Xa (Anti-FXa) Activity
- Enrolling
- 40 people
- Starts
- 2026-08-26
- Est. completion
- 2028-03-26
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 80 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Inpatient admission for acute traumatic injury ≥72 hours
- Prescribed LMWH subcutaneous for VTE chemoprophylaxis
You can't join if
- Pregnancy
- Brain hemorrhage or non-survivable injury
- Chronic Kidney disease ≥ 3b estimated Glomerular Filtration Rate (eGFR) less than 30 interferes with coagulation
- Chronic liver failure •-Acute stimulant use of cocaine and methamphetamine
- Active VTE or ongoing anticoagulation at admission
- History of coagulopathy or inherited bleeding disorders
- Chronic alcohol as defined as a documented diagnosis of alcohol use disorder or alcohol consumption exceeding established risk thresholds (men >14 drinks/week; women >7 drinks/week) within the prior 3-6 months
- Unmanaged psychiatric conditions as defined as diagnosed psychiatric disorder with evidence of inadequate or no active treatment or documented poor symptom control
- Neurologic injury involving hypothalamic or circadian regulatory centers
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openHCA Houston Northwest Medical Center
Houston, Texas, United States
- Evaline W Kihara, MSN, APRN, AGACNP-BC, CCRN · Contact(713) 500-6362Evaline.W.Kihara@uth.tmc.edu
- Nikhil Padhye · Contact(713) 500-2035Nikhil.S.Padhye@uth.tmc.edu
Recruiting
Study team
Sponsor
The University of Texas Health Science Center, Houston
Study ID HSC-SN-25-0184
Principal investigator
Evaline W Kihara, MSN, APRN, AGACNP-BC, CCRN
The University of Texas Health Science Center, Houston
Study director
Shiree Berry, MD
HCA Houston NW Medical center- Trauma Medical Director
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.